Event
EndoQuest Flexible Robotic System enters FDA Safer Technologies Program
FDA accepted EndoQuest Robotics' Flexible Robotic System into the Safer Technologies Program for Medical Devices.
Evidence notes
- The StEP acceptance applied to EndoQuest's flexible robotic system for endoluminal surgery, not to a general company milestone.
- FDA's Safer Technologies Program is intended to speed review interactions for devices expected to improve safety over available approaches.
- The event is regulatory pathway progress; it is not a clearance, approval or commercial deployment.
Company context
EndoQuest Robotics develops a flexible endoluminal surgical robot for procedures performed through the body’s natural orifices. Founded in Houston as ColubrisMX and rebranded in 2022, the company combines steerable endoscopy with robotic instrument control for upper and lower gastrointestinal interventions. Its investigational ELS System is intended to enable precise, scar-free surgery without external incisions.
Context
- Company
- EndoQuest Robotics
- Segment
- Surgical
- Event type
- Regulatory
- Added to Korthos
- Jul 15, 2026
- Geography
- Houston · United States